Literature DB >> 27091051

Prompt benefit of early immunosuppressive therapy in acute lymphocytic myocarditis with persistent heart failure.

Tatyana Weitsman1, Giora Weisz2, Andre Keren3, Tal Hasin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27091051     DOI： 10.1007/s00392-016-0985-x

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  9 in total

Review 1.  Viral damage or 'molecular mimicry'-placing the blame in myocarditis.

Authors:  N R Rose
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

2.  HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America.

Authors: 
Journal:  Pharmacotherapy       Date:  2000-05       Impact factor: 4.705

Review 3.  Myocarditis.

Authors:  A M Feldman; D McNamara
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

4.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Alida L P Caforio; Sabine Pankuweit; Eloisa Arbustini; Cristina Basso; Juan Gimeno-Blanes; Stephan B Felix; Michael Fu; Tiina Heliö; Stephane Heymans; Roland Jahns; Karin Klingel; Ales Linhart; Bernhard Maisch; William McKenna; Jens Mogensen; Yigal M Pinto; Arsen Ristic; Heinz-Peter Schultheiss; Hubert Seggewiss; Luigi Tavazzi; Gaetano Thiene; Ali Yilmaz; Philippe Charron; Perry M Elliott
Journal:  Eur Heart J       Date:  2013-07-03       Impact factor: 29.983

5.  Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders.

Authors:  Andrea Frustaci; Cristina Chimenti; Fiorella Calabrese; Maurizio Pieroni; Gaetano Thiene; Attilio Maseri
Journal:  Circulation       Date:  2003-02-18       Impact factor: 29.690

Review 6.  Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives.

Authors:  A L Caforio; J H Goldman; A J Haven; K M Baig; W J McKenna
Journal:  Int J Cardiol       Date:  1996-05       Impact factor: 4.164

7.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

Authors:  J W Mason; J B O'Connell; A Herskowitz; N R Rose; B M McManus; M E Billingham; T E Moon
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

8.  A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis.

Authors:  Alida L P Caforio; Fiorella Calabrese; Annalisa Angelini; Francesco Tona; Annalisa Vinci; Stefania Bottaro; Angelo Ramondo; Elisa Carturan; Sabino Iliceto; Gaetano Thiene; Luciano Daliento
Journal:  Eur Heart J       Date:  2007-05-09       Impact factor: 29.983

9.  Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study.

Authors:  Andrea Frustaci; Matteo A Russo; Cristina Chimenti
Journal:  Eur Heart J       Date:  2009-06-25       Impact factor: 29.983
  9 in total
  5 in total

1.  High incidence of cardiac dysfunction and response to antiviral treatment in patients with chronic hepatitis C virus infection.

Authors:  Wolfgang Poller; Ziya Kaya; Marion Muche; Mario Kasner; Carsten Skurk; Kai Kappert; Rudolf Tauber; Felicitas Escher; Heinz-Peter Schultheiss; Hans-Jörg Epple; Ulf Landmesser
Journal:  Clin Res Cardiol       Date:  2017-02-24       Impact factor: 5.460

2.  Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy.

Authors:  Felicitas Escher; Uwe Kühl; Dirk Lassner; Wolfgang Poller; Dirk Westermann; Burkert Pieske; Carsten Tschöpe; Heinz-Peter Schultheiss
Journal:  Clin Res Cardiol       Date:  2016-06-16       Impact factor: 5.460

3.  T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis.

Authors:  Ulf K Radunski; Gunnar K Lund; Dennis Säring; Sebastian Bohnen; Christian Stehning; Bernhard Schnackenburg; Maxim Avanesov; Enver Tahir; Gerhard Adam; Stefan Blankenberg; Kai Muellerleile
Journal:  Clin Res Cardiol       Date:  2016-07-07       Impact factor: 5.460

Review 4.  Myocarditis: A Clinical Overview.

Authors:  A L P Caforio; G Malipiero; R Marcolongo; S Iliceto
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 3.955

5.  Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella® CP): A Rare Case.

Authors:  Henrik Fox; Martin Farr; Dieter Horstkotte; Christian Flottmann
Journal:  Case Rep Cardiol       Date:  2017-07-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.